| [1] PubMed ID: | 31163553 |
| Disease Name: | laryngeal carcinoma |
| Sample: | laryngeal cancer tissues |
| Dysfunction Pattern: | Interaction[targeting miR-206] |
| Validated Method: | qRT-PCR//Luciferase Report Assay//MTT//Colony Formation Assay |
| Description: | : The expression of FOXD2-AS1 in laryngeal cancer tissues was significantly higher than that in normal tissues(t=10.012, P<0.05), and was associated with T staging of laryngeal cancer(χ=6.41, P=0.016). Double luciferase assay showed that FOXD2-AS1 could directly bind to miR-206, thus inhibiting the expression of miR-206. Further MTT assay indicated that inhibiting miR-206 attenuated the suppressing effect of si-FOXD2-AS1 on the proliferation of TU686 cells. |
| Causality: | Yes |
| Causal Description: | FOXD2-AS1 down regulated proliferation activity of TU686 cells(t=9.337, P<0.05). |
| Clinical-realted Application: | The expression of FOXD2-AS1 in laryngeal cancer tissues was significantly higher than that in normal tissues(t=10.012, P<0.05), and was associated with T staging of laryngeal cancer(χ=6.41, P=0.016). |